Last checked at Astra's Trastuzumab Deruxtecan Achieves Tumour Response Rate Of 60.9%
Astra's Trastuzumab Deruxtecan Achieves Tumour Response Rate Of 60.9%
11 Dec 19 13:41
- Home
- Share Prices
- AQSE Share Prices
- Share Chat
- FX
- News
- Blogs
- RNS
- Media
- Brokers
- Finance Tools
- Members
Latest Share Chat
Astrazeneca Share News (AZN)
AZN Share
Price
AZN Share
News16
AZN Share
Chat13
AZN Share
Trades14,938
AZN
Live RNS
AZN Share
Charts
AZN Level 2
Console
AZN Live
Share Price
AZN Broker
Ratings
AZN Directors
Deals
AZN Financial
Diary
AZN
Fundamentals
AZN Short
Positions
AZN
Media
AZN Information
Share Price Information for Astrazeneca (AZN)
Share Price is delayed by 15 minutes
Get Live Data
Share Price:
6,953.00
Bid:
6,953.00
Ask:
6,955.00
Change:
-57.00
(-0.81%)
Spread:
2.00 (0.03%)
Open:
7,001.00
High:
7,172.00
Low:
6,943.00
Yest. Close:
7,010.00
Last checked at -
Watchlists are a member only feature
Login to your account
Don't have an account? Click here to register.11 Dec 19 13:41AstraZeneca-Daiichi drug halts cancer for months in first readout
Dec 11 (Reuters) - An experimental cancer drug developed by AstraZeneca and Daiichi Sankyo kept metastatic breast cancer at bay for months in women who had exhausted other treatment options, its first clinical study showed.Patients on trastuzumab ...
11 Dec 19 13:00Tuesday broker round-up
(Sharecast News) - ASOS: HSBC upgrades to buy with a target price of 3,615p.
10 Dec 19 08:29DeepMatter shares surge as it announces AstraZeneca collaboration
(Sharecast News) - DeepMatter shares surged on Monday, after it announced a collaboration with AstraZeneca to use digital technologies to improve the productivity and reproducibility of compound synthesis.
9 Dec 19 14:07UK WINNERS & LOSERS SUMMARY: Tullow Plunges On Output Guidance Reset
UK WINNERS & LOSERS SUMMARY: Tullow Plunges On Output Guidance Reset
9 Dec 19 10:50UPDATE 2-UK shares weaken, Tullow loses half its market cap
* FTSE 100, FTSE 250 down 0.1%* Tesco outshines the main index* Some domestic stocks gain on election optimism* Tullow Oil plummets after co cancels dividend, CEO exits (Adds company news items, updates share moves)By Muvija M and Shashwat AwasthiDe...
9 Dec 19 09:23DeepMatter Shares Surge On AstraZeneca DigitalGlassware Collaboration
DeepMatter Shares Surge On AstraZeneca DigitalGlassware Collaboration
9 Dec 19 09:15Positive Results From AstraZeneca Trial Of Calquence Drug In Leukaemia
Positive Results From AstraZeneca Trial Of Calquence Drug In Leukaemia
9 Dec 19 06:51AstraZeneca, Merck Get Marketing Authorization In China For Lynparza
AstraZeneca, Merck Get Marketing Authorization In China For Lynparza
5 Dec 19 08:31AstraZeneca's Lynparza approved for use in China
(Sharecast News) - Biopharmaceutical company AstraZeneca announced on Thursday that Lynparza had been approved in China as a first-line maintenance therapy in BRCA-mutated advanced ovarian cancer.
5 Dec 19 08:27AstraZeneca-Merck Lynparza wins approval in China for ovarian cancer treatment
Dec 5 (Reuters) - AstraZeneca Plc and Merck & Co Inc said on Thursday that their drug, Lynparza, won approval in China as a first line treatment for a from of ovarian cancer.The approval in China is based on the results from a late-stage study in ...
5 Dec 19 07:11REFILE-AstraZeneca-Merck Lynparza wins approval in China for ovarian cancer treatment
(Corrects typo in the first paragraph)Dec 5 (Reuters) - AstraZeneca Plc and Merck & Co Inc said on Thursday that their drug, Lynparza, won approval in China as a first line treatment for a form of ovarian cancer.The approval in China is based on th...
5 Dec 19 07:11AstraZeneca Divests North American Seroquel and Seroquel XR Rights
AstraZeneca Divests North American Seroquel and Seroquel XR Rights
3 Dec 19 08:47AstraZeneca sells Seroquel rights in US and Canada
(Sharecast News) - AstraZeneca has agreed to sell the commercial rights to 'Seroquel' - quetiapine fumarate immediate release - and 'Seroquel XR' - quetiapine fumarate extended release - in the United States and Canada to Cheplapharm Arzneimittel, it announced on Tuesday.
3 Dec 19 07:29China to use drug bulk-buy program to close price gap
BEIJING, Nov 30 (Reuters) - China will use its national drug bulk-buy scheme to lower the price of drugs currently sold at higher prices compared with other markets, it said in an official statement.The move could force international drugmakers to...
30 Nov 19 15:47